Begegnungen im Vorraum der Macht. Carl Schmitt und Niklas Luhmann
- 期刊名称Deutsche Zeitschrift für Philosophie
- 作者Scholz, Leander
- 卷第59卷
- 期第3期
- 印刷ISSN0012-1045
- 文件大小201.04KB
- 发表时间2011-06
- DOI10.1524/dzph.2011.0029
- 页码359-368
Safety of monoclonal antibodies for the treatment of multiple sclerosisMcGinley, Marisa P; Moss, Brandon P; Cohen, Jeffrey A · Expert Opinion on Drug Safety · 2016
The safety of anti-interleukins monoclonal antibodies for the treatment of psoriasisD’Adamio, S; Silvaggio, D; Lombardo, P; Bianchi, L.; Talamonti, M; Galluzzo, M · Expert Opinion on Drug Safety · 2019
Monoclonal antibodies for the treatment of non-haematological tumours: a safety reviewCorsini, Lidia Rita; Fanale, Daniele; Passiglia, Francesco; Incorvaia, Lorena; Gennusa, Vincenzo; Bazan, Viviana; Russo, Antonio · Expert Opinion on Drug Safety · 2018
Safety of monoclonal antibodies and related therapeutic proteins for the treatment of neovascular macular degeneration: addressing outstanding issuesZiemssen, Focke; Sobolewska, Bianka; Deissler, Heidrun; Deissler, Helmut · Expert Opinion on Drug Safety · 2015
Safety and Tolerability of 514G3, a True Human Anti-Protein A Monoclonal Antibody for the Treatment of S. aureus BacteremiaHuynh, Toan; Stecher, Michael; Mckinnon, John; Jung, Norma; Rupp, Mark E. · Open Forum Infectious Diseases · 2016
A placebo randomized controlled study to test the efficacy and safety of GNbAC1, a monoclonal antibody for the treatment of multiple sclerosis – Rationale and designCurtin, Francois; Porchet, Herve; Glanzman, Robert; Schneble, Hans Martin; Vidal, Virginie; Audoli-Inthavong, Marie-Laure; Lambert, Estelle; Hartung, Hans Peter · Multiple Sclerosis and Related Disorders · 2016
Efficacy and safety of an interleukin 6 monoclonal antibody for the treatment of systemic lupus erythematosus: a phase II dose-ranging randomised controlled trialWallace, Daniel J; Strand, Vibeke; Merrill, Joan T; Popa, Serghei; Spindler, Alberto J; Eimon, Alicia; Petri, Michelle; Smolen, Josef S; Wajdula, Joseph; Christensen, Jared; Li, Cheryl; Diehl, Annette; Vincent, Michael S; Beebe, Jean; Healey, Paul; Sridharan, Sudhakar · Annals of the Rheumatic Diseases · 2017
Nicotinic acid: clinical considerationsKei, Anastazia; Elisaf, Moses S · Expert Opinion on Drug Safety · 2012
Drug safety evaluation of rosuvastatinToth, Peter P; Dayspring, Thomas D · Expert Opinion on Drug Safety · 2011
Gastrointestinal side effects of drugsMakins, Richard; Ballinger, Anne · Expert Opinion on Drug Safety · 2003
Capecitabine and hand–foot syndromeSaif, Muhammad Wasif · Expert Opinion on Drug Safety · 2011
Immune hemolytic anemia caused by drugsGarratty, George · Expert Opinion on Drug Safety · 2012
Thiazolidinedione safetyKung, Jacqueline; Henry, Robert R · Expert Opinion on Drug Safety · 2012
The safety of thiazolidinedionesTolman, Keith G · Expert Opinion on Drug Safety · 2011
Drug-induced immune hemolytic anemiaSalama, Abdulgabar · Expert Opinion on Drug Safety · 2009